Subscribe to our newsletter to receive the latest product updates and special offers

Order by Signal Tickers
Filters
Overview Valuation Financial Ownership Performance Technical ETF ETF Perf Custom Charts Tickers Basic TA News Snapshot Maps Stats
#41 / 200 Total
BCTX - BriaCell Therapeutics Corp - Stock Price Chart
TickerBCTX [NASD]
CompanyBriaCell Therapeutics Corp
CountryCanada
IndustryBiotechnology
Market Cap26.05MEPS (ttm)-1.67
P/E-EPS this Y-6.92%
Forward P/E-EPS next Y-0.72%
PEG-EPS past 5Y32.71%
P/S-EPS next 5Y-
P/B-EPS Q/Q7.71%
Dividend-Sales Q/Q-
Insider Own12.15%Inst Own14.03%
Insider Trans0.00%Inst Trans-
Short Float4.76%EarningsMar 19/b
Analyst Recom1.00Target Price18.00
Avg Volume68.20K52W Range2.01 - 7.59
Today 08:00AM BriaCell Therapeutics Announces Pricing of $5.0 Million Registered Direct Offering (GlobeNewswire) -22.75%
Apr-24-24 08:00AM BriaCell Announces Oral and Poster Presentations at ASCO 2024 (GlobeNewswire) -5.60%
Apr-10-24 08:00AM BriaCell 2024 AACR Preclinical Poster Confirms Strong Anti-Cancer Activity of Bria-OTS+ and Bria-PROS+ Clinical Candidates for Breast and Prostate Cancer (GlobeNewswire)
Apr-09-24 08:00AM BriaCell Showcases Data Demonstrating Unmatched Progression-Free Survival (PFS) and Clinical Efficacy in Antibody-Drug Conjugate (ADC) Resistant and Central Nervous System (CNS) Metastatic Breast Cancer at the 2024 AACR (GlobeNewswire)
Mar-19-24 06:52AM BCTX Stock Earnings: BriaCell Therapeutics Reported Results for Q2 2024 (InvestorPlace) -6.55%
Mar-07-24 08:00AM BriaCell Receives and Executes Letter of Intent to Advance Clinical Development of Breast and Prostate Cancer Immunotherapies (GlobeNewswire) -7.05%
Mar-06-24 08:00AM BriaCell to Present Clinical Data in Central Nervous System (CNS) Metastasis and Antibody-Drug Conjugate (ADC) Resistant Breast Cancer at the 2024 AACR Conference (GlobeNewswire) -8.24%
Feb-27-24 08:00AM BriaCell Provides Update on Alleged Illegal Trading of Public Securities (GlobeNewswire)
Feb-07-24 08:00AM BriaCell Announces Strong Clinical Data in Breast Cancer Patients; Reports Another Notable Responder Case (GlobeNewswire)
Feb-06-24 08:30AM Breaking Ground in Prostate Cancer: BriaCell Announces Lead Prostate Cancer Candidate Bria-Pros+, Initiates GMP Manufacturing (GlobeNewswire) +5.34%
MYSZ - My Size Inc - Stock Price Chart
TickerMYSZ [NASD]
CompanyMy Size Inc
CountryIsrael
IndustrySoftware - Application
Market Cap3.40MEPS (ttm)-24.06
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y49.60%
P/S0.49EPS next 5Y-
P/B0.51EPS Q/Q77.87%
Dividend-Sales Q/Q11.95%
Insider Own40.16%Inst Own7.16%
Insider Trans-1.79%Inst Trans-
Short Float7.78%EarningsNov 15/b
Analyst Recom1.00Target Price12.00
Avg Volume66.31K52W Range2.88 - 21.92
LUMO - Lumos Pharma Inc - Stock Price Chart
TickerLUMO [NASD]
CompanyLumos Pharma Inc
CountryUSA
IndustryBiotechnology
Market Cap18.19MEPS (ttm)-4.59
P/E-EPS this Y34.26%
Forward P/E-EPS next Y27.51%
PEG-EPS past 5Y20.27%
P/S11.97EPS next 5Y15.20%
P/B1.04EPS Q/Q-44.50%
Dividend-Sales Q/Q-76.12%
Insider Own39.19%Inst Own25.61%
Insider Trans-0.08%Inst Trans7.82%
Short Float6.07%EarningsMay 15/b
Analyst Recom1.00Target Price22.50
Avg Volume27.79K52W Range2.41 - 4.55
RETO - ReTo Eco-Solutions Inc - Stock Price Chart
TickerRETO [NASD]
CompanyReTo Eco-Solutions Inc
CountryChina
IndustryBuilding Materials
Market Cap6.67MEPS (ttm)-10.38
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-
P/S1.38EPS next 5Y-
P/B3.02EPS Q/Q-404.70%
Dividend-Sales Q/Q-57.31%
Insider Own17.95%Inst Own0.60%
Insider Trans0.00%Inst Trans-80.22%
Short Float1.96%Earnings-
Analyst Recom-Target Price-
Avg Volume162.18K52W Range0.86 - 73.60
XYLO - Xylo Technologies Ltd. ADR - Stock Price Chart
TickerXYLO [NASD]
CompanyXylo Technologies Ltd. ADR
CountryIsrael
IndustryMedical Devices
Market Cap3.89MEPS (ttm)-9.62
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-32.16%
P/S0.04EPS next 5Y-
P/B0.16EPS Q/Q-1104.85%
Dividend-Sales Q/Q-36.36%
Insider Own0.06%Inst Own0.18%
Insider Trans0.00%Inst Trans-44.19%
Short Float0.18%Earnings-
Analyst Recom1.00Target Price1350.00
Avg Volume14.90K52W Range1.50 - 7.17
BIG - Big Lots Inc - Stock Price Chart
TickerBIG [NYSE, RUT]
CompanyBig Lots Inc
CountryUSA
IndustryDiscount Stores
Market Cap115.97MEPS (ttm)-16.55
P/E-EPS this Y12.00%
Forward P/E-EPS next Y33.20%
PEG-EPS past 5Y-
P/S0.02EPS next 5Y-
P/B0.40EPS Q/Q-144.21%
Dividend-Sales Q/Q-7.17%
Insider Own4.50%Inst Own79.95%
Insider Trans0.91%Inst Trans-11.60%
Short Float26.96%EarningsMar 07/b
Analyst Recom3.67Target Price4.00
Avg Volume1.44M52W Range3.13 - 11.06
NNVC - NanoViricides Inc - Stock Price Chart
TickerNNVC [AMEX]
CompanyNanoViricides Inc
CountryUSA
IndustryBiotechnology
Market Cap21.20MEPS (ttm)-0.80
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y22.25%
P/S-EPS next 5Y-
P/B1.70EPS Q/Q-19.83%
Dividend-Sales Q/Q-
Insider Own4.62%Inst Own10.25%
Insider Trans0.00%Inst Trans19.17%
Short Float0.89%EarningsFeb 16/a
Analyst Recom1.00Target Price6.50
Avg Volume88.88K52W Range1.00 - 2.26
TSHA - Taysha Gene Therapies Inc - Stock Price Chart
TickerTSHA [NASD]
CompanyTaysha Gene Therapies Inc
CountryUSA
IndustryBiotechnology
Market Cap581.63MEPS (ttm)-1.16
P/E-EPS this Y59.00%
Forward P/E-EPS next Y-17.37%
PEG-EPS past 5Y-137.69%
P/S41.08EPS next 5Y-
P/B10.80EPS Q/Q62.67%
Dividend-Sales Q/Q-27.52%
Insider Own21.84%Inst Own62.46%
Insider Trans0.25%Inst Trans-1.76%
Short Float11.57%EarningsMay 14/a
Analyst Recom1.10Target Price6.95
Avg Volume2.88M52W Range0.50 - 3.89
CRIS - Curis Inc - Stock Price Chart
TickerCRIS [NASD]
CompanyCuris Inc
CountryUSA
IndustryBiotechnology
Market Cap76.57MEPS (ttm)-8.69
P/E-EPS this Y31.36%
Forward P/E-EPS next Y25.56%
PEG-EPS past 5Y14.56%
P/S7.81EPS next 5Y-
P/B8.10EPS Q/Q14.18%
Dividend-Sales Q/Q-9.19%
Insider Own0.18%Inst Own34.77%
Insider Trans0.00%Inst Trans-73.54%
Short Float1.14%EarningsMay 07/b
Analyst Recom1.33Target Price24.75
Avg Volume25.87K52W Range3.80 - 19.60
DATS - DatChat Inc - Stock Price Chart
TickerDATS [NASD]
CompanyDatChat Inc
CountryUSA
IndustrySoftware - Application
Market Cap4.97MEPS (ttm)-3.31
P/E-EPS this Y-
Forward P/E-EPS next Y-
PEG-EPS past 5Y-2.18%
P/S-EPS next 5Y-
P/B0.73EPS Q/Q65.17%
Dividend-Sales Q/Q-14.94%
Insider Own8.94%Inst Own1.28%
Insider Trans0.00%Inst Trans-
Short Float4.20%Earnings-
Analyst Recom-Target Price-
Avg Volume196.06K52W Range1.08 - 8.49
1234567891020